by Plus Therapeutics | Nov 1, 2024 | GBM
Come by our booth this weekend at @glioblastomaresearch Glioblastoma Summit in Miami; also featuring a presentation by Dr. Andrew Brenner, MD, PhD on Saturday! Our clinical and patient advocacy team will be on-site to share educational material and answer your...
by Plus Therapeutics | Oct 30, 2024 | Uncategorized
Come join us at the upcoming @the_abta 5K run in New York City! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics is proud to be a sponsor and will have a booth on-site to provide education about our clinical...
by Plus Therapeutics | Oct 29, 2024 | LM
Mark your calendars: We will be showcasing our Leptomeningeal Metastases programs at the 2024 SNO Annual Meeting in Houston, Texas! Plus Therapeutics will present data from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186Re) Obisbemeda for leptomeningeal...
by Plus Therapeutics | Oct 25, 2024 | GBM
Join us at the upcoming @glioblastomaresearch Glioblastoma Patient Summit as Plus Therapeutics takes the stage! The summit will be held November 1-3 in Miami, FL, and include panel talks from neurosurgeons and neuro-oncologists as well as an opportunity to connect...
by Plus Therapeutics | Oct 8, 2024 | GBM
#ICYMI Plus Therapeutics exhibited at the #CNS2024 Annual Meeting and Dr. John Floyd presented a ReSPECT-GBM clinical trial update Key Highlights:...
Recent Comments